Ultra-Hypofractionated vs Conventionally Fractionated Radiotherapy for Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Ultra-Hypofractionated Versus Conventionally Fractionated Radiotherapy for Prostate Cancer: 5-Year Outcomes of the HYPO-RT-PC Randomised, Non-Inferiority, Phase 3 Trial
Lancet 2019 Jun 18;[EPub Ahead of Print], A Widmark, A Gunnlaugsson, L Beckman, C Thellenberg-Karlsson, M Hoyer, M Lagerlund, J Kindblom, C Ginman, B Johansson, K Björnlinger, M Seke, M Agrup, P Fransson, B Tavelin, D Norman, B Zackrisson, H Anderson, E Kjellén, L Franzén, P NilssonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.